Live Breaking News & Updates on Davidm Schuster

Stay updated with breaking news from Davidm schuster. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New imaging tool is lighting up prostate cancer

Prostate cancer is the second most common cancer in men, with over 288,000 new cases diagnosed each year. It’s also one of the most curable cancers if detected early. ....

Davidm Schuster , Winship Cancer Institute Of Emory University , Winship Cancer Institute , Emory University , Morning Show , Prostate Cancer ,

Health Beat: Lighting up prostate cancer

A new imaging tool is transforming the way doctors detect and manage prostate cancer. ....

Davidm Schuster , Winship Cancer Institute Of Emory University , Winship Cancer Institute , Emory University , Get Scan , Medical Imaging , Prostate Cancer ,

U.S. FDA Approves Blue Earth Diagnostics' POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

POSLUMA will be commercially available in the United States in early June 2023 ....

United States , Scintomics Gmb , Davidm Schuster , Shelby Moneer , Davide Gauden , Brianf Chapin , Winship Cancer Institute Of Emory University , Emory University School Of Medicine , Division Of Surgery , Drug Administration , University Of Texas Md Anderson Cancer Center , A Siemens Healthineers Company , Department Of Urology , Technical University Of Munich , Solutions Inc , Blue Earth Diagnostics , Prostate Specific Membrane Antigen , Blue Earth Diagnostic , Siemens Healthineers , Chief Executive Officer , Blue Earth , Blue Earth Diagnostics Sponsored Phase , Associate Professor , Cancer Center , Coordinating Investigator , Emory University School ,

FDA Approves Imaging Agent With Radiohybrid Technology to Identify Location, Extent of Prostate Cancer

The radiohybrid imaging agent allowed positron emission tomography to identify prostate cancer with an 83% detection rate. ....

United States , Brianf Chapin , Davidm Schuster , Davide Gauden , Division Of Surgery , Department Of Urology , University Of Texas Md Anderson Cancer Center , Winship Cancer Institute At Emory University , Emory University School Of Medicine , Blue Earth Diagnostics , Adobe Stock , Cancer Center , Emory University School , Winship Cancer Institute ,

U.S. FDA Approves Blue Earth Diagnostics' POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

- POSLUMA will be commercially available in the United States in early June 2023 - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative ....

United Kingdom , United States , Clare Gidley , Mike Beyer , Priscilla Harlan , Shelby Moneer , Davidm Schuster , Brianf Chapin , Scintomics Gmb , Davide Gauden , Technical University Of Munich , Nuclear Medicine , Drug Administration , Department Of Urology , Emory University School Of Medicine , Corporate Communications , A Siemens Healthineers Company , Sam Brown Inc , Winship Cancer Institute Of Emory University , Solutions Inc , Division Of Surgery , Bracco Group , University Of Texas Md Anderson Cancer Center , Earth Diagnostics , Prostate Specific Membrane Antigen , Blue Earth Diagnostic ,